Kymera had a big week. This secretive hedge fund bought $172 million of its stock.

A secretive biotechnology-centered hedge fund bought shares of Kymera Therapeutics after the stock soared to its highest ...

Dupixent For Moderate-To-Severe Asthma Treatment Market Expected To Reach ~$8.1 Billion By 2032

Dupixent For Moderate-To-Severe Asthma Treatment Market Expected To Reach ~$8.1 Billion By 2032. December 13, 2025 7:27 am - The Dupixent market for moderate-to-severe asthma is valued at $3.25 ...